tiprankstipranks
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
OTLC
Oncotelic Therapeutics
RESEARCH TOOLSreports
Want to see OTLC full AI Analyst Report?

Oncotelic Therapeutics (OTLC) Financial Statements

86 Followers

Oncotelic Therapeutics Financial Overview

Oncotelic Therapeutics's market cap is currently $21.11M. The company's EPS TTM is $0.5851; its P/E ratio is 0.09; Oncotelic Therapeutics is scheduled to report earnings on May 25, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 70.00K$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 70.00K$ -12.84K$ -61.51K
Operating Income$ -3.19M$ -3.58B$ -6.65M$ -9.72M$ -9.13M
EBITDA$ -3.19M$ -3.55M$ -7.16M$ -5.60M$ -9.06M
Net Income$ 249.28M$ -4.52B$ -7.90M$ 17.82M$ -11.39M
Balance Sheet
Cash & Short-Term Investments$ 88.86B$ 86.13K$ 170.41K$ 241.45K$ 568.77K
Total Assets$ 10.00T>$ 26.68M$ 30.01M$ 36.12M$ 23.61M
Total Debt$ 16.27T$ 13.09M$ 12.57M$ 11.26M$ 8.99M
Net Debt$ 16.18T$ 13.00M$ 12.40M$ 11.02M$ 8.42M
Total Liabilities$ 10.00T>$ 19.20M$ 18.40M$ 16.92M$ 15.45M
Stockholders' Equity$ 10.00T>$ 8.25M$ 12.13M$ 19.41M$ 7.96M
Cash Flow
Free Cash Flow$ -1.38T$ -740.27K$ -1.32M$ -1.45M$ -4.43M
Operating Cash Flow$ -1.38T$ -740.27K$ -1.32M$ -1.45M$ -4.43M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 1.39T$ 656.00K$ 1.25M$ 1.13M$ 4.53M
Currency in USD

Oncotelic Therapeutics Earnings and Revenue History

Income Statement >

Oncotelic Therapeutics Debt to Assets

Balance Sheet >

Oncotelic Therapeutics Cash Flow

Cash Flow >

Oncotelic Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >